Key Points - Robbins LLP reminds investors of class action lawsuit against Tigo Energy (TYGO) between February 24, 2026 and August 4, 2026 - Lead plaintiff deadline for seeking recovery for alleged securities fraud violations is 11/23/2026 - Investigation announced into Tigo Energy, Inc. for possible violations of federal securities laws - Kaplan Fox &...
Key Points - Rosen Law Firm, Glancy Prongay Wolke & Rotter LLP, and Kaplan Fox &...
Key Points - September 28, 2026, is the deadline for investors to seek the role of...
Most sessions tell you nothing. These 6 moved Vaxart, Inc. (VXRT) enough to be worth explaining...
Here is what actually moved Achieve Life Sciences, Inc. (ACHV): the 6 sessions in the last...
from D.A. Davidson issued a price target of $115.00 for CFFI on 2026-09-28 20:15:11.The adjusted price target was set to $115.00.At the time of the announcement, CFFI was trading at...
Jake Civiello from D.A. Davidson issued a price target of $95.00 for CHMG on 2026-09-28 20:12:34.The adjusted price target was set to $95.00.At the time of the announcement, CHMG was...
from Jefferies issued a price target of $112.00 for KOD on 2026-09-28 18:24:19.The adjusted price target was set to $112.00.At the time of the announcement, KOD was trading at $89.92.The...
Matthew Hewitt from Craig-Hallum issued a price target of $6.28 for LFCR on 2026-09-28 17:58:31.The adjusted price target was set to $6.28.At the time of the announcement, LFCR was trading...
Matthew Caufield from H.C. Wainwright issued a price target of $96.00 for KOD on 2026-09-28 15:50:31.The adjusted price target was set to $96.00.At the time of the announcement, KOD was...
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
